Harrow (HROW) Debt Ratio (2011 - 2026)
Harrow (HROW) posted quarterly Debt Ratio of 0.7 for Q1 2026, up 125.36% year-over-year from 0.31 in Q1 2025, and up 14.37% quarter-over-quarter from 0.61 in Q4 2025.
Harrow (HROW) Debt Ratio (2011 - 2026) Analysis & Trends
Harrow's Debt Ratio history runs 14 years deep, the most recent figure standing at 0.7 for Q1 2026.
- In Q1 2026, Debt Ratio rose 125.36% year-over-year to 0.7; the TTM figure through Mar 2026 stood at 0.7 (up 125.36% YoY), while the FY2025 annual figure was 0.61, up 7.86% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.7, up from 0.61 in the prior quarter.
- The five-year high for Debt Ratio was 0.78 in Q1 2023, with the low at 0.11 in Q2 2025.
- The 5-year median for Debt Ratio is 0.64 (2023), against an average of 0.61.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio jumped 276.6% in 2022, then plunged 81.52% in 2025.
- Harrow's Debt Ratio stood at 0.66 in 2022, then declined by 10.04% to 0.6 in 2023, then dropped by 5.22% to 0.56 in 2024, then advanced by 7.86% to 0.61 in 2025, then gained by 14.37% to 0.7 in 2026.
- Business Quant data shows HROW's Debt Ratio at 0.7 in Q1 2026, 0.61 in Q4 2025, and 0.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 0.12 |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | 0.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.70 |
| Mar 31, 2026 | 0.70 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.56 |
| Sep 30, 2024 | 0.63 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | 0.62 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.78 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 0.73 |
| Jun 30, 2022 | 0.73 |
| Mar 31, 2022 | 0.74 |
| Dec 31, 2021 | 0.73 |
| Sep 30, 2021 | 0.70 |